Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

AHR ligands could treat inflammatory skin diseases.

A new topical treatment for hair loss is effective and safe with faster results.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Pexidartinib often causes liver issues and fatigue, especially in women.

A new topical treatment for hair loss is effective and safe with faster results.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

A new topical treatment for hair loss is effective and safe with faster results.

A new topical treatment for hair loss is effective and safe with faster results.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

RXRα is crucial for proper immune response and links diet to immune function.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Isoxazole 9 (ISX9) may help regrow hair by activating certain cell signals.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

JAK inhibitors offer new hope for treating severe alopecia areata.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

STITCH improves suture accuracy and efficiency, especially with human help.

Spanlastics effectively deliver Rizatriptan Benzoate with high efficiency and controlled release.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.